Tower Research Capital LLC TRC Cuts Stake in Addus HomeCare Co. (NASDAQ:ADUS)

Tower Research Capital LLC TRC lessened its stake in Addus HomeCare Co. (NASDAQ:ADUS) by 27.5% in the 4th quarter, Holdings Channel.com reports. The firm owned 739 shares of the company’s stock after selling 280 shares during the quarter. Tower Research Capital LLC TRC’s holdings in Addus HomeCare were worth $93,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of ADUS. Capital Research Global Investors purchased a new position in Addus HomeCare in the 4th quarter worth approximately $51,149,000. American Century Companies Inc. boosted its stake in Addus HomeCare by 695.8% during the 4th quarter. American Century Companies Inc. now owns 284,346 shares of the company’s stock valued at $35,643,000 after purchasing an additional 248,613 shares during the last quarter. TimesSquare Capital Management LLC increased its holdings in shares of Addus HomeCare by 28.5% in the 4th quarter. TimesSquare Capital Management LLC now owns 355,750 shares of the company’s stock worth $44,593,000 after purchasing an additional 78,835 shares in the last quarter. Principal Financial Group Inc. raised its stake in shares of Addus HomeCare by 17.5% in the third quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock worth $67,293,000 after purchasing an additional 75,409 shares during the last quarter. Finally, Pier Capital LLC bought a new position in shares of Addus HomeCare during the fourth quarter valued at $8,406,000. Institutional investors own 95.35% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the stock. Stephens reaffirmed an “overweight” rating and set a $142.00 price target on shares of Addus HomeCare in a report on Wednesday, March 12th. Macquarie raised their target price on shares of Addus HomeCare from $129.00 to $133.00 and gave the stock an “outperform” rating in a report on Thursday. StockNews.com lowered shares of Addus HomeCare from a “buy” rating to a “hold” rating in a research note on Wednesday, February 26th. JMP Securities restated a “market outperform” rating and issued a $150.00 price target on shares of Addus HomeCare in a research note on Tuesday, April 22nd. Finally, Oppenheimer lifted their price objective on Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. One equities research analyst has rated the stock with a hold rating, six have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Buy” and an average price target of $142.57.

Addus HomeCare Stock Up 0.2 %

Shares of Addus HomeCare stock opened at $110.91 on Friday. Addus HomeCare Co. has a twelve month low of $88.96 and a twelve month high of $136.72. The business has a 50-day moving average price of $98.86 and a 200-day moving average price of $114.47. The firm has a market cap of $2.04 billion, a price-to-earnings ratio of 25.38, a PEG ratio of 1.41 and a beta of 0.85.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings results on Monday, May 5th. The company reported $1.42 earnings per share for the quarter, beating the consensus estimate of $1.33 by $0.09. The business had revenue of $337.71 million during the quarter, compared to analysts’ expectations of $341.66 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm’s revenue for the quarter was up 20.3% compared to the same quarter last year. During the same quarter last year, the business posted $1.21 EPS. On average, equities analysts expect that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.